Screener
Nuvation Bio NUVB Total Cost of Revenue
Discontinued — last reported Q3 '25
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Nuvation Bio’s 10-Q, filed November 3, 2025.
- Filed
- Nov 3, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-262605
| Line item | For the Three Months Ended September 30, 2025 | For the Three Months Ended September 30, 2024 | For the Nine Months Ended September 30, 2025 | For the Nine Months Ended September 30, 2024 |
|---|---|---|---|---|
| Product revenue, net | $7,723 | — | $8,961 | — |
| Collaboration and license agreements revenue | 5,397 | 727 | 12,076 | 2,162 |
| Total revenues | 13,120 | 727 | 21,037 | 2,162 |
| Cost of revenue | 3,349 | 1,515 | 8,019 | 2,862 |
| Gross profit (deficit) | 9,771 | (788) | 13,018 | (700) |
| Operating expenses: | ||||
| Research and development | 28,846 | 27,731 | 80,809 | 69,820 |
| Acquired in-process research and development | — | — | — | 425,070 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's total cost of revenue?
- Nuvation Bio (NUVB) reported total cost of revenue of $3.35M in Q3 2025.
- How has Nuvation Bio's total cost of revenue changed year-over-year?
- Nuvation Bio's total cost of revenue increased by 121.1% year-over-year, from $1.52M to $3.35M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Nuvation Bio's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude